# Boston Scientific Corporation (BSX) — Q2-2012 Earnings Results

**Report date:** 2012-07-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2012

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 6.75%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.17 | N/A | +60.38% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding market conditions. They acknowledged the positive EPS surprise but noted external factors impacting revenue.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized the need for strategic adjustments moving forward.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a significant EPS beat, which is a positive sign for profitability. However, the stock dropped 6.75% in reaction, likely due to concerns over revenue performance and market challenges. Investors may be wary of the company's ability to sustain growth amidst these issues.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2012_